Literature DB >> 21682802

Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis.

S Borrell1, S Gagneux.   

Abstract

Mycobacterium tuberculosis harbours little DNA sequence diversity compared with other bacteria. However, there is mounting evidence that strain-to-strain variation in this organism has been underestimated. We review our current understanding of the genetic diversity among M. tuberculosis clinical strains and discuss the relevance of this diversity for the ongoing global epidemics of drug-resistant tuberculosis. Based on findings in other bacteria, we propose that epistatic interactions between pre-existing differences in strain genetic background, acquired drug-resistance-conferring mutations and compensatory changes could play a role in the emergence and spread of drug-resistant M. tuberculosis. 2011 The Authors. Clinical Microbiology and Infection; 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682802      PMCID: PMC3122159          DOI: 10.1111/j.1469-0691.2011.03556.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  60 in total

Review 1.  The biological cost of antibiotic resistance.

Authors:  D I Andersson; B R Levin
Journal:  Curr Opin Microbiol       Date:  1999-10       Impact factor: 7.934

Review 2.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

3.  Fitness cost of chromosomal drug resistance-conferring mutations.

Authors:  Peter Sander; Burkhard Springer; Therdsak Prammananan; Antje Sturmfels; Martin Kappler; Michel Pletschette; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

4.  Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

Authors:  O J Billington; T D McHugh; S H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

5.  A new evolutionary scenario for the Mycobacterium tuberculosis complex.

Authors:  R Brosch; S V Gordon; M Marmiesse; P Brodin; C Buchrieser; K Eiglmeier; T Garnier; C Gutierrez; G Hewinson; K Kremer; L M Parsons; A S Pym; S Samper; D van Soolingen; S T Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 6.  Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis.

Authors:  Christopher Dye; Brian G Williams; Marcos A Espinal; Mario C Raviglione
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

7.  Comparing genomes within the species Mycobacterium tuberculosis.

Authors:  M Kato-Maeda; J T Rhee; T R Gingeras; H Salamon; J Drenkow; N Smittipat; P M Small
Journal:  Genome Res       Date:  2001-04       Impact factor: 9.043

8.  Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex.

Authors:  Serge Mostowy; Debby Cousins; Jacqui Brinkman; Alicia Aranaz; Marcel A Behr
Journal:  J Infect Dis       Date:  2002-05-30       Impact factor: 5.226

9.  Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans.

Authors:  Alexander S Pym; Brigitte Saint-Joanis; Stewart T Cole
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.

Authors:  R D Fleischmann; D Alland; J A Eisen; L Carpenter; O White; J Peterson; R DeBoy; R Dodson; M Gwinn; D Haft; E Hickey; J F Kolonay; W C Nelson; L A Umayam; M Ermolaeva; S L Salzberg; A Delcher; T Utterback; J Weidman; H Khouri; J Gill; A Mikula; W Bishai; W R Jacobs; J C Venter; C M Fraser
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

View more
  44 in total

1.  Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.

Authors:  Mary A De Groote; Veronica Gruppo; Lisa K Woolhiser; Ian M Orme; Janet C Gilliland; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

Review 2.  Systems immunogenetics of vaccines.

Authors:  Michael Mooney; Shannon McWeeney; Rafick-Pierre Sékaly
Journal:  Semin Immunol       Date:  2013-07-22       Impact factor: 11.130

3.  Compensatory Mutations of Rifampin Resistance Are Associated with Transmission of Multidrug-Resistant Mycobacterium tuberculosis Beijing Genotype Strains in China.

Authors:  Qin-Jing Li; Wei-Wei Jiao; Qing-Qin Yin; Fang Xu; Jie-Qiong Li; Lin Sun; Jing Xiao; Ying-Jia Li; Igor Mokrousov; Hai-Rong Huang; A-Dong Shen
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 4.  Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.

Authors:  Claudio U Köser; Silke Feuerriegel; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

5.  Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.

Authors:  Lukas Fenner; Matthias Egger; Thomas Bodmer; Ekkehardt Altpeter; Marcel Zwahlen; Katia Jaton; Gaby E Pfyffer; Sonia Borrell; Olivier Dubuis; Thomas Bruderer; Hans H Siegrist; Hansjakob Furrer; Alexandra Calmy; Jan Fehr; Jesica Mazza Stalder; Béatrice Ninet; Erik C Böttger; Sebastien Gagneux
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

6.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

Review 7.  Old and new selective pressures on Mycobacterium tuberculosis.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Infect Genet Evol       Date:  2011-08-17       Impact factor: 3.342

Review 8.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Borna Müller; Sonia Borrell; Graham Rose; Sebastien Gagneux
Journal:  Trends Genet       Date:  2012-12-13       Impact factor: 11.639

9.  The Mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic molecules.

Authors:  Olga Danilchanka; David Pires; Elsa Anes; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

10.  Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission.

Authors:  M de Vos; B Müller; S Borrell; P A Black; P D van Helden; R M Warren; S Gagneux; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.